Literature DB >> 27774216

Just compensation: a no-fault proposal for research-related injuries.

Leslie Meltzer Henry1, Megan E Larkin2, Elizabeth R Pike3.   

Abstract

Biomedical research, no matter how well designed and ethically conducted, carries uncertainties and exposes participants to risk of injury. Research injuries can range from the relatively minor to those that result in hospitalization, permanent disability, or even death. Participants might also suffer a range of economic harms related to their injuries. Unlike the vast majority of developed countries, which have implemented no-fault compensation systems, the United States continues to rely on the tort system to compensate injured research participants-an approach that is no longer morally defensible. Despite decades of US advisory panels advocating for no-fault compensation, little progress has been made. Accordingly, this article proposes a novel and necessary no-fault compensation system, grounded in the ethical notion of compensatory justice. This first-of-its-kind concrete proposal aims to treat like cases alike, offer fair compensation, and disburse compensation with maximum efficiency and minimum administrative cost. It also harmonizes national and international approaches-an increasingly important goal as research becomes more globalized, multi-site trials grow in number, and institutions and sponsors in the United States move to single-IRB review.

Entities:  

Keywords:  clinical trial; compensation; compensatory justice; no-fault compensation; remedy; research injury

Year:  2015        PMID: 27774216      PMCID: PMC5034397          DOI: 10.1093/jlb/lsv034

Source DB:  PubMed          Journal:  J Law Biosci        ISSN: 2053-9711


  6 in total

1.  Integrating Rules for Genomic Research, Clinical Care, Public Health Screening and DTC Testing: Creating Translational Law for Translational Genomics.

Authors:  Susan M Wolf; Pilar N Ossorio; Susan A Berry; Henry T Greely; Amy L McGuire; Michelle A Penny; Sharon F Terry
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

2.  What Should We Be Asking of Informed Consent?

Authors:  Ellen Wright Clayton
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.604

3.  Removing One Barrier to Protecting Sex Partners in HIV Remission Studies With a Treatment Interruption.

Authors:  Nir Eyal
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

4.  Scientific, ethical, and legal considerations for the inclusion of pregnant people in clinical trials.

Authors:  Catherine A Sewell; Sarah M Sheehan; Mira S Gill; Leslie Meltzer Henry; Christina Bucci-Rechtweg; Cynthia Gyamfi-Bannerman; Anne D Lyerly; Leslie C McKinney; Kimberly P Hatfield; Gerri R Baer; Leyla Sahin; Christine P Nguyen
Journal:  Am J Obstet Gynecol       Date:  2022-08-04       Impact factor: 10.693

Review 5.  Regulating international clinical research: an ethical framework for policy-makers.

Authors:  Bernardo Aguilera; David DeGrazia; Annette Rid
Journal:  BMJ Glob Health       Date:  2020-05

Review 6.  Are errors in otorhinolaryngology always a sign of medical malpractice? Review of the literature and new perspectives in the SARS-CoV-2 (COVID-19) era.

Authors:  Polychronis Voultsos; Antonio Oliva; Simone Grassi; Debora Palmiero; Antonio Gioacchino Spagnolo
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-06-10       Impact factor: 2.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.